CN101679395B - 三唑基氨基嘧啶化合物 - Google Patents

三唑基氨基嘧啶化合物 Download PDF

Info

Publication number
CN101679395B
CN101679395B CN2008800157689A CN200880015768A CN101679395B CN 101679395 B CN101679395 B CN 101679395B CN 2008800157689 A CN2008800157689 A CN 2008800157689A CN 200880015768 A CN200880015768 A CN 200880015768A CN 101679395 B CN101679395 B CN 101679395B
Authority
CN
China
Prior art keywords
ethyl
alkyl
methyl
amino
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008800157689A
Other languages
English (en)
Chinese (zh)
Other versions
CN101679395A (zh
Inventor
H·B·布鲁克斯
J·Z·克里奇
J·R·亨利
胡红
蒋德炉
李宏宇
W·T·麦米伦
J·S·索耶
M·K·斯拉特
王延
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN101679395A publication Critical patent/CN101679395A/zh
Application granted granted Critical
Publication of CN101679395B publication Critical patent/CN101679395B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN2008800157689A 2007-05-16 2008-05-07 三唑基氨基嘧啶化合物 Expired - Fee Related CN101679395B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93834707P 2007-05-16 2007-05-16
US60/938,347 2007-05-16
PCT/US2008/062808 WO2008144223A2 (en) 2007-05-16 2008-05-07 Triazolyl aminopyrimidine compounds

Publications (2)

Publication Number Publication Date
CN101679395A CN101679395A (zh) 2010-03-24
CN101679395B true CN101679395B (zh) 2012-06-13

Family

ID=39951591

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008800157689A Expired - Fee Related CN101679395B (zh) 2007-05-16 2008-05-07 三唑基氨基嘧啶化合物

Country Status (15)

Country Link
US (1) US8063035B2 (cg-RX-API-DMAC7.html)
EP (1) EP2155734A2 (cg-RX-API-DMAC7.html)
JP (1) JP5248600B2 (cg-RX-API-DMAC7.html)
KR (1) KR101131261B1 (cg-RX-API-DMAC7.html)
CN (1) CN101679395B (cg-RX-API-DMAC7.html)
AR (1) AR066473A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008254319B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0811433A2 (cg-RX-API-DMAC7.html)
CA (1) CA2691997A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008001323A1 (cg-RX-API-DMAC7.html)
EA (1) EA016781B1 (cg-RX-API-DMAC7.html)
MX (1) MX2009012228A (cg-RX-API-DMAC7.html)
PE (1) PE20090216A1 (cg-RX-API-DMAC7.html)
TW (1) TW200908981A (cg-RX-API-DMAC7.html)
WO (1) WO2008144223A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964729B2 (en) 2006-08-28 2011-06-21 Massachusetts Institute Of Technology Sox-based kinase sensor
US8101628B2 (en) 2006-12-21 2012-01-24 Eli Lilly And Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
SI2125794T1 (sl) 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
US8440835B2 (en) 2007-02-26 2013-05-14 Massachusetts Institute Of Technology Environmentally sensitive fluorophores
EA016781B1 (ru) 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) * 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds
KR101123178B1 (ko) * 2009-04-09 2012-06-13 (주)에스메디 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
EP2470652A1 (en) * 2009-08-25 2012-07-04 OncoTherapy Science, Inc. Ercc6l as target genes for cancer therapy and diagnosis
WO2011025546A1 (en) * 2009-08-31 2011-03-03 Massachusetts Institute Of Technology 1, 2, 3-triazole containing protein kinase sensors
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
US9611201B2 (en) * 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
JP7090037B2 (ja) * 2016-06-23 2022-06-23 エフ.ホフマン-ラ ロシュ アーゲー 新規な[1,2,3]トリアゾロ[4,5-d]ピリミジン誘導体
US11084829B2 (en) 2018-09-24 2021-08-10 Rapt Therapeutics, Inc. Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
KR20220059951A (ko) * 2019-09-05 2022-05-10 더 유니버시티 오브 멜버른 질화 억제제
CN112341428A (zh) * 2020-11-04 2021-02-09 菏泽鸿特药业有限公司 一种噻吩-2-乙胺的生产方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007599A2 (en) * 1988-02-09 1989-08-24 Georgia State University Foundation, Inc. Novel diazines and their method of preparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004063192A1 (en) 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
JP2007533602A (ja) * 2003-07-31 2007-11-22 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 置換ベンゾチオフェン化合物及びそれらの使用
AU2005316312B2 (en) * 2004-12-17 2009-10-22 Amgen, Inc. Aminopyrimidine compounds and methods of use
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8008481B2 (en) 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
US8101628B2 (en) 2006-12-21 2012-01-24 Eli Lilly And Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
SI2125794T1 (sl) * 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
EA016781B1 (ru) 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007599A2 (en) * 1988-02-09 1989-08-24 Georgia State University Foundation, Inc. Novel diazines and their method of preparation

Also Published As

Publication number Publication date
EP2155734A2 (en) 2010-02-24
AU2008254319A1 (en) 2008-11-27
US8063035B2 (en) 2011-11-22
WO2008144223A3 (en) 2009-02-05
EA016781B1 (ru) 2012-07-30
JP5248600B2 (ja) 2013-07-31
MX2009012228A (es) 2009-12-01
EA200971068A1 (ru) 2010-04-30
KR101131261B1 (ko) 2012-04-24
CL2008001323A1 (es) 2009-05-29
WO2008144223A2 (en) 2008-11-27
US20100087431A1 (en) 2010-04-08
JP2010527365A (ja) 2010-08-12
TW200908981A (en) 2009-03-01
AR066473A1 (es) 2009-08-19
KR20090130242A (ko) 2009-12-21
PE20090216A1 (es) 2009-02-28
CA2691997A1 (en) 2008-11-27
CN101679395A (zh) 2010-03-24
AU2008254319B2 (en) 2012-04-19
BRPI0811433A2 (pt) 2016-03-22

Similar Documents

Publication Publication Date Title
CN101679395A (zh) 三唑基氨基嘧啶化合物
US9206130B2 (en) Quinoline derivatives as AXL kinase inhibitors
CN101568539B (zh) 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物
US8114872B2 (en) Triazolyl aminopyrimidine compounds
CN101563342B (zh) 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120613

Termination date: 20150507

EXPY Termination of patent right or utility model